Diagnostics and therapeutic interventions in myocardial interstitial disease, a previously neglected pathology

Area of Science:

• Cardiology
• Biomedical Engineering
• Pharmacology

Background:

• Cardiac fibrosis, a myocardial interstitial disease, predicts adverse outcomes in heart disease.
• It contributes to cardiac stiffness, arrhythmias, hypoxia, and heart failure.
• Current diagnosis and treatment of cardiac fibrosis are limited, with elusive underlying mechanisms.

Purpose of the Study:

• To review recent advances in understanding cardiac fibrosis.
• To highlight progress in imaging techniques and biomarker discovery for myocardial interstitial disease.
• To emphasize the need for better detection and understanding of molecular mechanisms for targeted therapies.

Main Methods:

• Review of recent scientific literature on cardiac fibrosis.
• Analysis of advances in cardiac imaging and biomarker discovery.
• Discussion of emerging evidence on fibrosis reversibility and pharmacological intervention.

Main Results:

• Significant advances in imaging and biomarkers improve understanding of myocardial interstitial remodelling.
• Emerging evidence indicates cardiac fibrosis may be reversible.
• Potential for pharmacological intervention in treating heart fibrosis.

Conclusions:

• Cardiac fibrosis remains a significant challenge in heart disease management.
• Recent breakthroughs offer hope for improved detection and treatment.
• Further research into molecular biology is crucial for developing specific anti-remodelling therapies.